Changes in Hemorrhage With Prophylactic Oxytocin for Dilation and Evacuation
ConditionHemorrhage
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexFemale
Age18-55
SponsorUniversity of Colorado, Denver
About this trial
The purpose of this study is to assess the effectiveness of prophylactic oxytocin on hemorrhage rates for second trimester dilation and evacuation (D\&E) in the clinic setting.
Eligibility criteria
Qualifiers
clinic-based D&E at 18 weeks gestational age and above
speaks English or Spanish
Disqualifiers
refuses IV
history of coagulopathy
anticoagulant use in the preceding five days
chorioamnionitis or sepsis
Trial design
Treatments tested in this trial
- Oxytocin + normal saline
- Normal saline
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov